Suchergebnisse - Mathurin Fumery
- Treffer 1 - 20 von 57
- Zur nächsten Seite
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Use of imaging modalities for decision-making in inflammatory bowel disease von Stéphane Nancey, Mathurin Fuméry, Mathias Faure, Gilles Boschetti, Claire Gay, Laurent Milot, Xavier Roblin
Veröffentlicht 2023Revisão -
8
-
9
-
10
-
11
-
12
Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis von Mathurin Fuméry, Parambir S. Dulai, Samir Gupta, Larry J. Prokop, Sonia Ramamoorthy, William J. Sandborn, Siddharth Singh
Veröffentlicht 2016Revisão -
13
Systematic review with meta‐analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases von Siddharth Singh, Parambir S. Dulai, Niels Vande Casteele, Robert Battat, Mathurin Fuméry, Brigid S. Boland, William J. Sandborn
Veröffentlicht 2019Revisão -
14
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses von Nghia Nguyen, Mathurin Fuméry, Parambir S. Dulai, Larry J. Prokop, William J. Sandborn, M. Hassan Murad, Siddharth Singh
Veröffentlicht 2018Revisão -
15
No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analy... von Clara Yzet, Momar Diouf, Siddarth Singh, Franck Brazier, Justine Turpin, Éric Nguyen-Khac, Jonathan Meynier, Mathurin Fuméry
Veröffentlicht 2020Revisão -
16
No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials von Siddharth Singh, J. Proudfoot, Parambir S. Dulai, Vipul Jairath, Mathurin Fuméry, Ronghui Xu, Brian G. Feagan, William J. Sandborn
Veröffentlicht 2018Revisão -
17
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis von Siddharth Singh, M. Hassan Murad, Mathurin Fuméry, Rocío Sedaño, Vipul Jairath, Remo Panaccione, William J. Sandborn, Christopher Ma
Veröffentlicht 2021Revisão -
18
Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Anal... von Siddharth Singh, Mathurin Fuméry, Abha Singh, Namrata Singh, Larry J. Prokop, Parambir S. Dulai, William J. Sandborn, Jeffrey R. Curtis
Veröffentlicht 2019Revisão -
19
Young Adult Patients With Paediatric‐Onset Inflammatory Bowel Disease Have a Higher Educational Level and a Higher Employment Rate Than the General Population von Hélène Sarter, Mathilde Le Coniac, Ariane Leroyer, Guillaume Savoye, Mathurin Fuméry, Nathalie Guillon, Corinne Gower‐Rousseau, Delphine Ley, Dominique Turck
Veröffentlicht 2025Artigo -
20
Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease von Clara Yzet, Momar Diouf, Jean‐Philippe Le Mouel, Franck Brazier, Justine Turpin, Julien Loreau, Jean Louis Dupas, Laurent Peyrin–Biroulet, Mathurin Fuméry
Veröffentlicht 2019Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Medicine
Internal medicine
Disease
Gastroenterology
Crohn's disease
Surgery
Inflammatory bowel disease
Ulcerative colitis
Cohort
Environmental health
Meta-analysis
Population
Infliximab
Physics
Cohort study
Pediatrics
Cancer
Inflammatory Bowel Diseases
MEDLINE
Pathology
Ustekinumab
Vedolizumab
Adverse effect
Colorectal cancer
Intensive care medicine
Law
Political science
Randomized controlled trial
Tumor necrosis factor alpha
Incidence (geometry)